Kara Toman is the Director of Clinical Research at Baylor College of Medicines Dan L Duncan Comprehensive Cancer Center. With a Master of Public Health from UTHealth Houston, her expertise spans clinical trial management, regulatory compliance, and process improvement, with prior experience at McKesson.
She has co-authored research on the financial toxicity of cancer treatment for patients in safety-net hospitals.
Kara Toman, MPH
Director of Clinical Research - Dan L Duncan Cancer Center at Baylor College of Medicine
Houston, Texas, United States
Overview
Topics They Care About
Cancer Research
As the Director of Clinical Research for the Dan L Duncan Comprehensive Cancer Center, this is her primary professional focus.
Clinical Trial Management
Her career at Baylor College of Medicine and McKesson has been dedicated to managing and directing clinical research operations.
Patient Financial Burden
She co-authored a publication focused on the "financial toxicity" of prostate cancer treatment, showing an interest in patient-centric issues.
Media Appearances
Kara has no verified media appearances
Work History
8-2023
Director of Clinical Research - Dan L Duncan Cancer Center at Baylor College of Medicine
5-2018 - 8-2023
Senior Research Director, Pediatric Urology at Baylor College of Medicine
8-2016 - 5-2018
Lead Regulatory Affairs Manager, Pediatric Research Resources Office at Baylor College of Medicine
12-2013 - 7-2015
Associate Director of Clinical Research Operations at McKesson
6-2013 - 12-2013
Research Program Manager at McKesson
Clinical Research Manager, OBGYN at Baylor College of Medicine
Graduate Research Assistant at The University of Texas Health Science Center at Houston
Education
Master of Public Health (M.P.H.) from UTHealth Houston
Bachelor of Arts (B.A.) from Augusta University
More Information
Social Presence :
Prographics :
Exp : 11
Location : Houston, Texas, United States
Job Level : Mid-senior
Designation : Director of Clinical Research - Dan L Duncan Cancer Center at Baylor College of Medicine
